Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Oh Pez

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Sep 28, 2021 9:57am

67 Views

Post# 33929976

RE:Oh Pez

Still flexing a car that doesn’t belong to you lmao Do I need to repost your previous comments on this stock and humiliate you again?

Speaking of taking the L, it’s about time you go to your therapist.

Rarbar99 wrote:
When this company was $1.40-1.55 I was warning everyone here to sell.

You are the reason why many people continued to hold on and dropped another 15-20%

If you idiots had listened to me, you would have sold in the 1.40s and bought back in the 1.15s.

Next time listen to the guy who drives a 1/4 million dollar car, not the guy who keeps taking L's after L's.